Navigating the Gardasil 9 Vaccine for Individuals Ages 27-45: Five Key Points to Consider Before Your Shot

Dr. Le Thi Truc Phuong, a Medical Specialist at the VNVC Vaccination System, has emphasized the importance of understanding key information about the Gardasil 9 vaccine before receiving it. The vaccine is now available for individuals up to 45 years old, an expansion from the previous limit of 26 years. However, there is a lack of awareness regarding vaccine effectiveness, correct vaccination age, and vaccination regimen among this age group.

To ensure the best possible vaccination experience, Dr. Phuong has compiled and explained five crucial points that individuals aged 27-45 should be aware of before receiving the HPV vaccine. Firstly, clinical studies have shown that Gardasil 9 produces good immunogenicity in this age group with a general effectiveness of protecting against high-risk HPV strains by more than 90%. Secondly, individuals aged 27-45 should follow a three-shot regimen at months 0-2-6 without requiring a booster shot. Studies have demonstrated that this regimen produces strong immunity and maintains high antibody levels for up to 30 years. Thirdly, anyone between the ages of 9 and 45 can receive the HPV vaccine regardless of their age or season as HPV can be transmitted through various means. Fourthly, there are certain contraindications for HPV vaccination such as allergies to vaccine components, previous hypersensitivity reactions to the vaccine, active infections blood clotting disorders and pregnancy. Lastly